Apimeds Pharmaceuticals US, Inc. (APUS)
NYSEAMERICAN: APUS · Real-Time Price · USD
1.850
-0.080 (-4.15%)
At close: Jan 30, 2026, 4:00 PM EST
1.880
+0.030 (1.62%)
After-hours: Jan 30, 2026, 8:00 PM EST
APUS Market Cap
APUS has a market cap or net worth of $23.27 million as of January 30, 2026.
Market Cap
23.27M
Enterprise Value
n/a
1-Year Change
n/a
Ranking
Category
Stock Price
$1.85
Market Cap Chart
Since the IPO on December 9, 2025, APUS's market cap has decreased from $26.79M to $23.27M, a decrease of -13.15%. That is a compound annual growth rate of -62.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 23.27M | 12.80% |
| Dec 31, 2025 | 20.62M | -23.00% |
| Dec 9, 2025 | 26.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InterCure | 50.99M |
| Zhengye Biotechnology Holding | 47.39M |
| Talphera | 46.14M |
| Rockwell Medical | 44.53M |
| BioXcel Therapeutics | 36.74M |
| SCYNEXIS | 32.51M |
| Aytu BioPharma | 26.69M |
| TherapeuticsMD | 24.77M |